Royalty Pharma Announces R&D Funding Collaboration With Biogen
Go back to Royalty Pharma Announces R&D Funding Collaboration With Biogen| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 61.01 -0.3 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.31 | 52 Week High | $3.48 | |||
| Open | $61.20 | 52 Week Low | $0.80 | |||
| Day High | $61.26 | P/E | N/A | |||
| Day Low | $60.80 | EPS | $-1.54 | |||
| Volume | 57,567 | |||||
